Stock Screener App

Frei -

Installieren

225.71

3.33% 7.28

Biogen Inc (BIIB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Biogen Inc-Aktie (BIIB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.70% 2,477.80	2,279.40	2,534.70	2,645.50	2,431.00
Cost Of Revenue	33.40% 661.00	495.50	674.40	605.00	629.30
Selling, General, and Administrative	607.30	-	-	-	-
Interest Income/Expense	0.15% 67.60	67.50	67.40	72.60	60.00
Costs And Expenses	10.08% 2,100.10	2,335.40	1,977.40	1,901.50	2,119.80
Income/Loss From Continuing Operations Before Tax	774.46% 377.70	-56.00	557.30	744.00	311.20
Income Tax Expense/Benefit, Current	58.20	-	-	-	70.70
Income Tax Expense/Benefit, Deferred	85.86% 23.60	166.90	253.80	-31.30	-27.80
Income Tax Expense/Benefit	919.72% 58.20	-7.10	90.80	109.20	70.70
Net Income/Loss	753.37% 319.50	-48.90	466.50	634.80	240.50
Basic Average Shares	147.10K% 147.20	0.10	146.60	146.50	146.10
Diluted Average Shares	49,367% 148.40	0.30	147.10	146.70	146.60
Basic Earnings Per Share	757.58% 2.17	-0.33	3.18	4.33	1.65
Diluted Earnings Per Share	714.29% 2.15	-0.35	3.17	4.33	1.64

GRFS

$7.46

0.67%

OGN

$13.81

0.44%

AMRN

$12.03

0.33%

NSRX

$3.51

3.31%

MIRA

$0.7455

6.05%

SCLX

$2.92

1.35%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters